[go: up one dir, main page]

FR2780901B1 - Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant - Google Patents

Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant

Info

Publication number
FR2780901B1
FR2780901B1 FR9808809A FR9808809A FR2780901B1 FR 2780901 B1 FR2780901 B1 FR 2780901B1 FR 9808809 A FR9808809 A FR 9808809A FR 9808809 A FR9808809 A FR 9808809A FR 2780901 B1 FR2780901 B1 FR 2780901B1
Authority
FR
France
Prior art keywords
monosaccharides
oligosaccharides
nanoparticles
cosmetic
crosslinked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9808809A
Other languages
English (en)
Other versions
FR2780901A1 (fr
Inventor
Marie Christine Levy
Nadine Pariot
Florence Edwards
Marie Christine Andry
Goutenoire Sylvie Rey
Chantal Buffevant
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Coletica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coletica SA filed Critical Coletica SA
Priority to FR9808809A priority Critical patent/FR2780901B1/fr
Priority to NL1012517A priority patent/NL1012517C2/nl
Priority to KR19990027476A priority patent/KR100799407B1/ko
Priority to DE19932216A priority patent/DE19932216B4/de
Priority to JP19670599A priority patent/JP3437797B2/ja
Priority to IT1999TO000599A priority patent/IT1311514B1/it
Priority to US09/350,131 priority patent/US6197757B1/en
Priority to ES009901547A priority patent/ES2155793B1/es
Publication of FR2780901A1 publication Critical patent/FR2780901A1/fr
Application granted granted Critical
Publication of FR2780901B1 publication Critical patent/FR2780901B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/795—Composed of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Saccharide Compounds (AREA)
FR9808809A 1998-07-09 1998-07-09 Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant Expired - Lifetime FR2780901B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9808809A FR2780901B1 (fr) 1998-07-09 1998-07-09 Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
NL1012517A NL1012517C2 (nl) 1998-07-09 1999-07-05 Deeltjes, in het bijzonder microdeeltjes of nanodeeltjes van dwarsverbonden monosacchariden en oligosacchariden, werkwijze voor het bereiden hiervan en cosmetische, farmaceutische of levensmiddelen samenstellingen waarin deze aanwezig zijn.
KR19990027476A KR100799407B1 (ko) 1998-07-09 1999-07-08 가교된 단당류 및 올리고당류의 입자 특히 마이크로입자 또는 나노입자, 이들의 제조방법 및 이들이 존재하는 화장품, 제약 또는 식품 조성물
JP19670599A JP3437797B2 (ja) 1998-07-09 1999-07-09 架橋された単糖及びオリゴ糖の粒子、特にマイクロ粒子又はナノ粒子、それらの調製法、並びに、それらを含有する化粧用、医薬用又は食物組成物
DE19932216A DE19932216B4 (de) 1998-07-09 1999-07-09 Teilchen, insbesondere Mikroteilchen oder Nanoteilchen, aus vernetzten Monosacchariden und Oligosacchariden, Verfahren zu deren Herstellung und Verwendung der Teilchen als kosmetisches Mittel oder zur Herstellung pharmazeutischer Zusammensetzungen oder Nahrungsmittelzusammensetzungen
IT1999TO000599A IT1311514B1 (it) 1998-07-09 1999-07-09 Particelle, specialmente microparticelle o nanoparticelle, dioligosaccaridi e monosaccaridi reticolati, procedimenti per la loro
US09/350,131 US6197757B1 (en) 1998-07-09 1999-07-09 Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present
ES009901547A ES2155793B1 (es) 1998-07-09 1999-07-09 Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808809A FR2780901B1 (fr) 1998-07-09 1998-07-09 Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant

Publications (2)

Publication Number Publication Date
FR2780901A1 FR2780901A1 (fr) 2000-01-14
FR2780901B1 true FR2780901B1 (fr) 2000-09-29

Family

ID=9528466

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9808809A Expired - Lifetime FR2780901B1 (fr) 1998-07-09 1998-07-09 Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant

Country Status (8)

Country Link
US (1) US6197757B1 (fr)
JP (1) JP3437797B2 (fr)
KR (1) KR100799407B1 (fr)
DE (1) DE19932216B4 (fr)
ES (1) ES2155793B1 (fr)
FR (1) FR2780901B1 (fr)
IT (1) IT1311514B1 (fr)
NL (1) NL1012517C2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617580B2 (en) 2007-02-01 2013-12-31 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
US12156946B2 (en) 2007-02-01 2024-12-03 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010926C2 (nl) * 1998-12-30 2000-07-03 Inst Voor Agrotech Onderzoek Werkwijze voor de bereiding van zetmeeldeeltjes.
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
FR2824756B1 (fr) * 2001-05-16 2005-07-08 Mainelab Microcapsules a base de proteines vegetales
KR100483193B1 (ko) * 2001-06-05 2005-04-14 꼴레띠까 처리된 비수용성 고체 미립자, 그 미립자의 제조 및 사용법
FR2825293B1 (fr) * 2001-06-05 2004-05-07 Coletica Particules solides insolubles dans l'eau traitees, preparation et utilisation
BR0212833A (pt) * 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US20050233003A1 (en) * 2001-09-28 2005-10-20 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
US20050227911A1 (en) * 2001-09-28 2005-10-13 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
US6878693B2 (en) 2001-09-28 2005-04-12 Solubest Ltd. Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US20030084914A1 (en) * 2001-11-08 2003-05-08 L'oreal Cosmetic articles having encapsulated liquid and method of making same
US7700851B2 (en) * 2001-11-13 2010-04-20 U.S. Smokeless Tobacco Company Tobacco nicotine demethylase genomic clone and uses thereof
FR2832632B1 (fr) 2001-11-26 2004-04-23 Mane Fils V Capsule a solubilisation et liberation du contenu rapides
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
FR2847163B1 (fr) * 2002-11-19 2006-07-28 Jean Claude Epiphani Procede d'hydrosolubilisation d'un parfum et solution obtenue par le procede
FR2848847B1 (fr) * 2002-12-18 2005-10-14 Coletica Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations
FR2848854B1 (fr) * 2002-12-24 2005-03-18 Coletica Particules comprenant un biopolymere degradable sous l'effet d'une onde electromagnetique telle qu'emise par un rayonnement solaire
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
US7923030B2 (en) 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
DE10315538A1 (de) * 2003-04-04 2004-10-21 Siemens Ag Teilchen mit einer Membran
CA2532874A1 (fr) * 2003-07-22 2005-02-03 Baxter International Inc. Petites particules spheriques de molecules organiques de faible poids moleculaire et procedes de preparation et d'utilisation correspondants
EP1504664A1 (fr) * 2003-07-29 2005-02-09 Novartis AG Composes organiques
BRPI0413131A (pt) 2003-07-31 2007-04-10 Sol Gel Technologies Ltd micro-cápsulas carregadas com ingredientes ativos e um método para sua preparação
WO2005055947A2 (fr) * 2003-12-08 2005-06-23 Yu Ruey J Optimisation d'organes et de sites cutaneo-muqueux ou cutanes au moyen de compositions topiques
WO2005060610A2 (fr) * 2003-12-11 2005-07-07 The Trustees Of Columbia University In The City Ofnew York Particules a taille nanometrique, leurs procedes d'obtention, compositions et leurs utilisations
US8241655B2 (en) * 2004-05-12 2012-08-14 Surmodics, Inc. Coatings for medical articles including natural biodegradable polysaccharides
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
GB2423252B (en) 2005-02-18 2007-10-17 Engelhard Lyon Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols
FR2882366B1 (fr) * 2005-02-18 2008-04-18 Coletica Sa Polymere reticule de carbohydrate, notamment a base de polysaccharides et/ou de polyols
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
WO2006138202A2 (fr) * 2005-06-14 2006-12-28 Baxter International Inc. Preparations pharmaceutiques permettant de reduire les interactions entre medicaments
TWI466897B (zh) * 2005-07-19 2015-01-01 Glytech Inc 癌細胞之檢測方法、糖鏈之構造解析方法，以及糖鏈衍生物
CN101277757B (zh) 2005-08-02 2011-11-30 索尔-格尔科技有限公司 非水溶性成分的金属氧化物涂布
RU2313538C2 (ru) * 2005-08-04 2007-12-27 Борис Олегович Майер Хитозановый продукт, способ его получения (варианты)
GB0516761D0 (en) * 2005-08-16 2005-09-21 Eastman Kodak Co Particulate polymeric material
ATE540705T1 (de) * 2005-09-21 2012-01-15 Surmodics Inc Überzüge und artikel mit natürlichen biologisch abbaubaren polysacchariden
ATE454908T1 (de) * 2005-09-21 2010-01-15 Surmodics Inc In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
WO2007059515A2 (fr) * 2005-11-15 2007-05-24 Baxter International, Inc. Compositions d'inhibiteurs de lipoxygenase
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
JP5694664B2 (ja) * 2006-09-29 2015-04-01 サーモディクス，インコーポレイティド 生分解性眼用インプラント及び眼の病気を治療する方法
US20090297626A1 (en) * 2006-11-03 2009-12-03 The Trustees Of Columbia University In The City Of New York Methods for preparing metal oxides
US20080154241A1 (en) * 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
JP5763525B2 (ja) * 2008-05-07 2015-08-12 サーモディクス，インコーポレイティド 粒子からの核酸複合体の送達
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
ES2919933T3 (es) 2011-03-18 2022-07-29 Int Flavors & Fragrances Inc Microcápsulas producidas a partir de precursores de sol-gel combinados y método de producción de las mismas
ITTO20110372A1 (it) * 2011-04-28 2012-10-29 Univ Degli Studi Torino Metodo per la preparazione di nanospugne di destrine
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US9056208B2 (en) * 2013-02-07 2015-06-16 Conopco Inc. Personal care compositions that include enrobed sugar
WO2015035245A1 (fr) 2013-09-06 2015-03-12 The Regents Of The University Of California Particules d'oxyde métallique dotées de revêtements polymères multicouches uniformes
EP3342406B1 (fr) * 2015-08-24 2024-03-20 Shanxi Yabao Investment Group Co., Ltd. Dihydroxyacétone pour l'utilisation dans la préparation d'un médicament anti-tumoral
KR101762011B1 (ko) 2015-09-02 2017-07-26 최화숙 3중매트릭스캡슐화가 가능한 화장료 조성물 및 이의 제조방법
CN106349396A (zh) * 2016-08-26 2017-01-25 湖南尔康制药股份有限公司 一种具有超声敏感性的交联淀粉
ES3040940T3 (en) 2017-07-12 2025-11-05 Sol Gel Tech Ltd Compositions comprising encapsulated tretinoin
CA3079303A1 (fr) * 2017-10-16 2019-04-25 Faes Farma, S.A. Compositions aqueuses comprenant de la bilastine et du mometasone
CA3060806A1 (fr) * 2018-11-09 2020-05-09 Winfield Solutions, Llc Hydrogels comme supports d`ingredients actifs et methodes de production
CA3060477A1 (fr) 2018-11-09 2020-05-09 Windfield Solutions, Llc Hydrogels comme modificateurs de rheologie et methodes de fabrication
CN115551473A (zh) * 2020-05-08 2022-12-30 派弗·兰根有限两合公司 包含纤维糊精的化妆品组合物
WO2021243188A1 (fr) * 2020-05-29 2021-12-02 Hemp Synergistics Huile de cannabis en poudre
KR20240015891A (ko) 2022-07-28 2024-02-06 주식회사 수안향장 이중 매트릭스 캡슐의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472835A (en) * 1964-02-12 1969-10-14 American Mach & Foundry Schardinger dextrins
US4774329A (en) * 1987-08-04 1988-09-27 American Maize-Products Company Controlled release agent for cetylpyridinium chloride
US4902788A (en) * 1988-09-29 1990-02-20 Uop Crosslinked cyclodextrins supported on porous refractory inorganic oxides
US4958015A (en) * 1988-09-30 1990-09-18 Uop Preparation of crosslinked cyclodextrin resins with enhanced porosity
US5395620A (en) * 1989-01-31 1995-03-07 Coletica Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside
CA2042529C (fr) * 1990-08-10 2002-07-30 Chokyun Rha Article contenant de la polysaccharide et ses utilisations
HK1006946A1 (en) * 1991-06-03 1999-03-26 Nycomed Imaging As Improvements in or relating to contrast agents
JPH0778126B2 (ja) * 1992-02-10 1995-08-23 日清紡績株式会社 多糖類真球状粒子及び製造方法
FR2688422A1 (fr) * 1992-03-11 1993-09-17 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
US5321064A (en) * 1992-05-12 1994-06-14 Regents Of The University Of Minnesota Compositions of biodegradable natural and synthetic polymers
SE470353B (sv) * 1992-06-22 1994-01-31 Volvo Penta Ab Båtpropellerdrev med automatiskt trimorgan
DK103393D0 (da) * 1993-09-15 1993-09-15 Ferrosan As Praeparat

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617580B2 (en) 2007-02-01 2013-12-31 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
US12156946B2 (en) 2007-02-01 2024-12-03 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating

Also Published As

Publication number Publication date
JP3437797B2 (ja) 2003-08-18
NL1012517C2 (nl) 2000-01-11
ES2155793B1 (es) 2001-12-01
KR100799407B1 (ko) 2008-01-30
JP2000038402A (ja) 2000-02-08
ITTO990599A1 (it) 2001-01-09
US6197757B1 (en) 2001-03-06
KR20000011579A (ko) 2000-02-25
IT1311514B1 (it) 2002-03-13
ES2155793A1 (es) 2001-05-16
DE19932216B4 (de) 2005-12-08
FR2780901A1 (fr) 2000-01-14
DE19932216A1 (de) 2000-01-27

Similar Documents

Publication Publication Date Title
FR2780901B1 (fr) Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
FR2766090B1 (fr) Particules, en particulier micro- ou nanoparticules de proteines vegetales reticulees, leur procede de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
Almoudi et al. A systematic review on antibacterial activity of zinc against Streptococcus mutans
FR2755136B1 (fr) Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant
EP0392608A3 (fr) Produit solide d'utilisateur contenant des complexes de cyclodextrines sous forme de particules fines
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
CA2233108A1 (fr) Complexe de gamma-cyclodextrine et de retinol ou de derives de retinol, processus de preparation et utilisation
NO20015782D0 (no) Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
NZ501950A (en) Medicinal compositions for application to mucosa
BR9805775A (pt) Composição de aplicação tópica, utilização de pelo menos um polìmero dispersìvel e um polìmero solúvel, utilização de pelo menos um polìmero formador de filme dispersìvel e um polìmero solúvel, processo de cuidado cosmético ou de maquilagem dos lábios ou da pele e processo cosmético.
BR9814818A (pt) Métodos de tratamento de cápsulas e formulações farmacêuticas em pó secas
FR2787789B1 (fr) Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
BRPI0417666B1 (pt) composição para tratamento oral ou pessoal.
ES2125099T3 (es) Composiciones que comprenden nanoparticulas de un antiinflamatorio no estereoideo.
AU4680800A (en) Biomimetic water solutions and compositions, their use as and in health and beauty care products and the methods to prepare them
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
RU95100769A (ru) Порошкообразная косметическая композиция для обесцвечивания волос, способ ее получения способ обесцвечивания волос
CA2182030A1 (fr) Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
WO2002098349A3 (fr) Procede d'utilisation de particules optiquement actives dans des preparations cosmetiques
FR2825293B1 (fr) Particules solides insolubles dans l'eau traitees, preparation et utilisation
BR9907470A (pt) Utilização de uma fase particular, composição cosmética e processo de tra tamento não terapêutico das matérias queratìnicas
FR2819175B1 (fr) Composition cosmetique et/ou dermatologique acide contenant un polymere amphiphile
WO2000054733A3 (fr) Supports souples et absorbants, pourvus de dispersions de nanoparticules, pour le traitement de la peau
BR0317805B1 (pt) Composição de cuidados oral ou pessoal
FR2796070B1 (fr) Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20